Big Pharma made this a big year for Indian drugmakers. As multinational companies sought ways to cut costs and grow revenues, they ramped up their outsourcing programs and partnerships–and that has helped push sales growth past 20 percent for India’s leading drugmakers, such as Ranbaxy Laboratories, Cipla, Dr Reddy’s Laboratories, and Aurobindo Pharma, the Business Standard reports. That’s quite a leap; these big Indian pharmas been growing at an annual clip of about 12 percent over the past five years. And it’s quite a boost to particular companies’ ambitious goals. Let’s take a look at the GlaxoSmithKline-Dr Reddy’s partnership. In June, the two companies announced a deal to develop and market certain products in emerging markets outside India. Dr Reddys is charged with manufacturing the products;